Fr. 52.50

Toxicologic Pathology Of Contraceptive In Womens - Experimental Study of Toxicologic Pathology of Contraceptive Compound used by Human Females

English, German · Paperback / Softback

Shipping usually within 2 to 3 weeks (title will be printed to order)

Description

Read more

The present research project was done on contraceptive using rats as experimental model. The study was for six month by oral intubation of contraceptive LD each S.C tablet contain: Levonorgestrel 0.15 mg and Ethinyl Estradiol 0.03 mg. The study was done on tow groups of eight male and eight female rats. First group as untreated control and the second group treated. For the first three months treated group were given by oral gavage one tablet dissolved in water to every treated rats and in the last three months, the dose was increase to tablet for every animals. Histopathological changes were suppression of spermatogenisis in testis in males and atrophy of ovaries in female, furthermore there were histopathological changes in liver, kidney, heart, lung, skeletal muscle, skin, epidedymus and prostate.

About the author










Professor Assistente Bahaa Al-Sereah, já tenho mais de (40) artigos publicados. além disso, tenho também cerca de (7) livros científicos publicados em vários campos da patologia e da patologia toxicológica.

Product details

Authors Baha Al-Sereah, Bahaa Al-Sereah, Mohammed Hassan, Sale Majeed, Saleh Majeed
Publisher LAP Lambert Academic Publishing
 
Languages English, German
Product format Paperback / Softback
Released 31.07.2015
 
EAN 9783659750274
ISBN 978-3-659-75027-4
No. of pages 84
Subject Natural sciences, medicine, IT, technology > Medicine > Pharmacy

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.